EMEA-001724-PIP01-14 - paediatric investigation plan
Levomilnacipran
PIPHuman
Pierre Fabre Medicament
France
Tel. +33 149108081
P/0128/2015: EMA decision of 5 June 2015 on the refusal of a product-specific waiver for levomilnacipran (EMEA-001724-PIP01-14)